| Year |
Citation |
Score |
| 2023 |
Smith NJ, Deaton TK, Territo W, Graner B, Gauger A, Snyder SE, Schulte ML, Green MA, Hutchins GD, Veronesi MC. Hybrid F-Fluoroethyltyrosine PET and MRI with Perfusion to Distinguish Disease Progression from Treatment-Related Change in Malignant Brain Tumors: The Quest to Beat the Toughest Cases. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. PMID 37116915 DOI: 10.2967/jnumed.122.265149 |
0.331 |
|
| 2018 |
Vāvere AL, Neumann KD, Butch ER, Hu B, DiMagno SG, Snyder SE. Improved, One-pot Synthesis of 6-[ F] Fluorodopamine and Quality Control Testing for Use in Patients with Neuroblastoma. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 30289176 DOI: 10.1002/Jlcr.3685 |
0.316 |
|
| 2015 |
Neumann KD, Qin L, Vāvere AL, Shen B, Miao Z, Chin FT, Shulkin BL, Snyder SE, DiMagno SG. Efficient automated syntheses of high specific activity 6-[(18) F]fluorodopamine using a diaryliodonium salt precursor. Journal of Labelled Compounds & Radiopharmaceuticals. PMID 26695865 DOI: 10.1002/Jlcr.3367 |
0.33 |
|
| 2015 |
Hu B, Va̅vere AL, Neumann KD, Shulkin BL, DiMagno SG, Snyder SE. A Practical, Automated Synthesis of meta-[(18)F]Fluorobenzylguanidine for Clinical Use. Acs Chemical Neuroscience. PMID 26313342 DOI: 10.1021/Acschemneuro.5B00202 |
0.313 |
|
| 2013 |
Laser BS, Merchant TE, Indelicato DJ, Hua CH, Shulkin BL, Snyder SE. Evaluation of children with craniopharyngioma using carbon-11 methionine PET prior to proton therapy. Neuro-Oncology. 15: 506-10. PMID 23408862 DOI: 10.1093/neuonc/nos321 |
0.321 |
|
| 2008 |
Li X, Jung YW, Snyder SE, Blair J, Sherman PS, Desmond T, Frey KA, Kilbourn MR. 5-tert-Butyl-2-(4′-[18F]fluoropropynylphenyl)-1,3-dithiane oxides: potential new GABAA receptor radioligands Nuclear Medicine and Biology. 35: 549-559. PMID 18589299 DOI: 10.1016/J.Nucmedbio.2007.08.003 |
0.582 |
|
| 2006 |
Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR. Imaging butyrylcholinesterase activity in Alzheimer's disease. Annals of Neurology. 60: 746. PMID 17192935 DOI: 10.1002/Ana.21023 |
0.407 |
|
| 2006 |
Kuhl DE, Koeppe RA, Snyder SE, Minoshima S, Frey KA, Kilbourn MR. In vivo butyrylcholinesterase activity is not increased in Alzheimer's disease synapses. Annals of Neurology. 59: 13-20. PMID 16278840 DOI: 10.1002/Ana.20672 |
0.485 |
|
| 2005 |
Shao X, Koeppe RA, Butch ER, Kilbourn MR, Snyder SE. Evaluation of 18F-labeled acetylcholinesterase substrates as PET radiotracers Bioorganic and Medicinal Chemistry. 13: 869-875. PMID 15653352 DOI: 10.1016/J.Bmc.2004.10.034 |
0.672 |
|
| 2003 |
Shao X, Butch ER, Kilbourn MR, Snyder SE. N-[18F]fluoroethylpiperidinyl, N-[18F]fluoroethylpiperidinemethyl and N-[18F]fluoroethylpyrrolidinyl esters as radiotracers for acetylcholinesterase Nuclear Medicine and Biology. 30: 491-500. PMID 12831986 DOI: 10.1016/S0969-8051(03)00031-3 |
0.66 |
|
| 2003 |
Shao X, Lisi JM, Butch ER, Kilbourn MR, Snyder SE. N-methylpiperidinemethyl, N-methylpyrrolidyl and N-methylpyrrolidinemethyl esters as PET radiotracers for acetylcholinesterase activity Nuclear Medicine and Biology. 30: 293-302. PMID 12745021 DOI: 10.1016/S0969-8051(02)00438-9 |
0.634 |
|
| Show low-probability matches. |